Fibroblast growth factor receptor 4, implicated in progression of islet cell carcinogenesis by its expression profile, does not contribute functionally

Cell Growth and Differentiation

Volumn 9, Issue 7, 1998, Pages 557-564

  Olson, David C ^a   Deng, Chuxia ^b   Hanahan, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; GENE EXPRESSION; MOUSE; NONHUMAN; PANCREAS ISLET CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ADENOMA, ISLET CELL; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, TRANSGENIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RECEPTORS, FIBROBLAST GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 0031816438     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Armstrong, E., Vainikka, S., Partanen, J., Korhonen, J., and Alitalo, R. Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res., 52: 2004-2007, 1992.
2. Coutts, J. C., and Gallagher, J. T. Receptors for fibroblast growth factors, Immunol. Cell. Biol., 73: 584-589, 1995.
3. Givol, D., and Yayon, A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J., 6: 3362-3369, 1992.
4. Hughes, S. E., and Hall, P. A. Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc. Res., 27: 1199-203, 1993.
5. Johnson, D. E., and Williams, L T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60: 1-41, 1993.
6. Rosenquist, T. A., and Martin, G. R. Fibroblast growth factor signalling in the hair growth cycle: expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle. Dev. Dyn., 205: 379-386, 1996.
7. Rousseau, F., Bonaventure, J., Legeai-Mallet, L, Pelet, A., Rozet, J. M., Maroteaux, P., Le Merrer, M., and Munnich, A. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm. Res., 45: 108-110, 1996.
8. Gao, G., and Goldfarb, M. Heparin can activate a receptor tyrosine kinase. EMBO J., 14: 2183-2190, 1995.
9. Jaye, M., Schlessinger, J., and Dionne, C. A. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta, 1135: 185-199, 1992.
10. Kanai, M., Goke, M., Tsunekawa, S., and Podolsky, D. K. Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein. J. Biol. Chem., 272: 6621-6628, 1997.
11. Li, Y., Basilico, C., and Mansukhani, A. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol., 14: 7660-7669, 1994.
12. Pertovaara, L, Tienari, J., Vainikka, S., Partanen, J., Saksela, O., Lehtonen, E., and Alitalo, K. Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cells. Biochem. Biophys. Res. Commun., 191: 149-156, 1993.
13. Shaoul, E., Reich-Slotky, R., Berman, B., and Ron, D. Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene, 10: 1553-1561, 1995.
14. Vainikka, S., Joukov, V., Wennstrom, S., Bergman, M., Pelicci, P. G., and Alitalo, K. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J. Biol. Chem., 269: 18320-18326, 1994.
15. Wang, J. K., Gao, G., and Goldfarb, M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol., 14: 181-188, 1994.
16. Abbass, S. A., Asa, S. L., and Ezzat, S. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J. Clin. Endocrinol. Metab., 82: 1160-1166, 1997.
17. Chesi, M., Nardini, E., Brents, L. A., Schrock, E., Ried, T., Kuehl, W. M., and Bergsagel, P. L. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat. Genet., 16: 260-264, 1997.
18. Jaakkola, S., Salmikangas, P., Nylund, S., Partanen, J., Armstrong, E., Pyrhonen, S., Lehtovirta, P., and Nevanlinna, H. Amplification of fgfr4 gene in human breast and gynecological cancers. Int. J. Cancer, 54: 378-382, 1993.
19. Leung, H. Y., Gullick, W. J., and Lemoine, N. R. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int. J. Cancer, 59: 667-675, 1994.
20. Luqmani, Y. A., Mortimer, C., Yiangou, C., Johnston, C. L., Bansal, G. S., Sinnett, D., Law, M., and Coombes, R. C. Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast. Int. J. Cancer, 64: 274-279, 1995.
21. Mattei, S., Colombo, M. P., Melani, C., Silvani, A., Parmiani, G., and Herlyn, M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer, 56: 853-857, 1994.
22. McLeskey, S. W., Ding, I. Y., Lippman, M. E., and Kern, F. G. MDAMB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res., 54: 523-530, 1994.
23. Mummery, C. L., van Rooyen, M., Bracke, M., van den Eijndenvan Raaij, J., van Zoelen, E. J., and Alitalo, K. Fibroblast growth factor-mediated growth regulation and receptor expression in embryonal carcinoma and embryonic stem cells and human germ cell tumours. Biochem. Biophys. Res. Commun., 191: 188-195, 1993.
24. Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A. T., and Neri, A. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood, 90: 4062-4070, 1997.
25. Hanahan, D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature (Lond.), 315: 115-122, 1985.
26. Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., and Baekkeskov, S. β-Cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA, 85: 9037-9041, 1988.
27. Naik, P., Christofori, G., and Hanahan, D. Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis. Cold Spring Harbor Symp. Quant. Biol., 59: 459-470, 1994.
28. Naik, P., Karrim, J., and Hanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10: 2105-2116, 1996.
29. Arbeit, J. M., Olson, D. C., and Hanahan, D. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene, 13: 1847-1857, 1996.
30. Morrison, R. S., Yamaguchi, F., Saya, H., Bruner, J. M., Yahanda, A. M., Donehower, L. A., and Berger, M. Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J. Neurooncol., 18: 207-216, 1994.
31. Story, M. T., Hopp, K. A., Molter, M., and Meier, D. A. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors, 10: 269-280, 1994.
32. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84: 911-921, 1996.
33. Johnston, C. L., Cox, H. C., Gomm, J. J., and Coombes, R. C. bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement. Biochem. J., 306: 609-616, 1995.
34. Jouanneau, J., Gavrilovic, J., Caruelle, D., Jaye, M., Moens, G., Caruelle, J. P., and Thiery, J. P. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. USA, 88: 2893-2897, 1991.
35. Burgess, W. H., and Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem., 58: 575-606, 1989.
36. Klagsbrun, M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin. Cancer Biol., 3: 81-87, 1992.
37. Vlodavsky, I., Fuks, Z., Ishai-Michaeli, R., Bashkin, P., Levi, E., Korner, G., Bar-Shavit, R., and Klagsbrun, M. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J. Cell. Biochem., 45: 167-176, 1991.
38. Ali, J., Mansukhani, A., and Basilico, C. Fibroblast growth factor receptors 1 and 2 are differentially regulated in murine embryonal carcinoma cells and in response to fibroblast growth factor-4. J. Cell. Physiol., 165: 438-448, 1995.
39. Pizette, S., Coulier, F., Birnbaum, D., and DeLapeyriere, O. FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells. Exp. Cell Res., 224: 143-151, 1996.
40. Prudovsky, I., Savion, N., Zhan, X., Friesel, R., Xu, J., Hou, J., McKeehan, W. L., and Maciag, T. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem., 269: 31720-31724, 1994.
41. Yayon, A., and Klagsbrun, M. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cancer Metastasis Rev., 9: 191-202, 1990.
42. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994.
43. Lamm, G. M., and Christofori, G. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. Cancer Res., 58: 801-807, 1998.
44. Radvanyi, F., Christgau, S., Baekkeskov, S., Jolicoeur, C., and Hanahan, D. Pancreatic β cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Mol. Cell. Biol., 13: 4223-4232, 1993.
45. Hogan, B. L., Constantini, E., and Lacey, E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1986.
46. Smith, K. M., Olson, D. C., Hirose, R., and Hanahan, D. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Int. Immunol., 9: 1355-1365, 1997.
47. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol., 119: 493-501, 1992.